Evidence map›Paper›PMID 34569712›Full record

ArticleESC heart failure2021

Characteristics and outcomes of heart failure with recovered left ventricular ejection fraction.

Xinxin Zhang, Yuxi Sun, Yanli Zhang, Feifei Chen, Mengyuan Dai, Jinping Si, Jing Yang, Xiao Li, Jiaxin Li, Yunlong Xia and 2 more

Abstract read
In one paragraph

Article in ESC heart failure, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Observational
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Xinxin ZhangHeart Failure and Structural Cardiology Division, First Affiliated Hospital of Dalian Medical University, Dalian, China.
Yuxi SunHeart Failure and Structural Cardiology Division, First Affiliated Hospital of Dalian Medical University, Dalian, China.
Yanli ZhangHeart Failure and Structural Cardiology Division, First Affiliated Hospital of Dalian Medical University, Dalian, China.
Feifei ChenHeart Failure and Structural Cardiology Division, First Affiliated Hospital of Dalian Medical University, Dalian, China.
Mengyuan DaiHeart Failure and Structural Cardiology Division, First Affiliated Hospital of Dalian Medical University, Dalian, China.
Jinping SiHeart Failure and Structural Cardiology Division, First Affiliated Hospital of Dalian Medical University, Dalian, China.
Jing YangHeart Failure and Structural Cardiology Division, First Affiliated Hospital of Dalian Medical University, Dalian, China.
Xiao LiHeart Failure and Structural Cardiology Division, First Affiliated Hospital of Dalian Medical University, Dalian, China.
Jiaxin LiHeart Failure and Structural Cardiology Division, First Affiliated Hospital of Dalian Medical University, Dalian, China.
Yunlong XiaHeart Failure and Structural Cardiology Division, First Affiliated Hospital of Dalian Medical University, Dalian, China.
Gary TseHeart Failure and Structural Cardiology Division, First Affiliated Hospital of Dalian Medical University, Dalian, China.ORCID 0000-0001-5510-1253
Ying LiuHeart Failure and Structural Cardiology Division, First Affiliated Hospital of Dalian Medical University, Dalian, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsThere is an emerging interest in elucidating the natural history and prognosis for patients with heart failure with reduced ejection fraction (HFrEF) in whom left ventricular ejection fraction (LVEF) subsequently improves. The characteristics and outcomes were compared between heart failure with recovered ejection fraction (HFrecEF) and persistent HFrEF. METHODS AND

resultsThis is a retrospective study of adults who underwent at least two echocardiograms 3 months apart between 1 November 2015 and 31 October 2019 with an initial diagnosis of HFrEF. The subjects were divided into HFrecEF group (second LVEF > 40%, ≥10% absolute improvement in LVEF) and persistent HFrEF group (<10% absolute improvement in LVEF) according to the second LVEF. To further study the characteristics of HFrecEF patients, the cohort was further divided into LVEF improvement of 10-20% and >20% subgroups. The primary outcomes were all-cause mortality and rehospitalization. A total of 1160 HFrEF patients were included [70.2% male, mean (standard deviation) age: 62 ± 13 years]. On the second echocardiogram, 284 patients (24.5%) showed HFrecEF and 876 patients (75.5%) showed persistent HFrEF. All-cause mortality was identified in 23 (8.10%) HFrecEF and 165 (18.84%) persistent HFrEF, whilst 76 (26.76%) and 426 (48.63%) showed rehospitalizations, respectively. Survival analysis showed that the persistent HFrEF subgroup experienced a significantly higher mortality at 12 and 24 months and a higher hospitalization at 12, 24, 48, and more than 48 months following discharge. Multivariate Cox regression showed that persistent HFrEF had a higher risk of all-cause mortality [hazard ratio (HR) 2.30, 95% confidence interval (CI) 1.49-3.56, P = 0.000] and rehospitalization (HR 1.85, 95% CI 1.45-2.36, P = 0.000) than the HFrecEF group. Subgroup analysis showed that the LVEF ≥ 20% improvement subgroup had lower rates of adverse outcomes compared with those with less improvement of 10-20%.

conclusionsHeart failure with recovered ejection fraction is a distinct HF phenotype with better clinical outcomes compared with those with persistent HFrEF. HFrecEF patients have a relatively better short-term mortality at 24 months but not thereafter.

Indexed as

Heart FailureVentricular Dysfunction, LeftFemaleHumansMaleRetrospective StudiesStroke VolumeVentricular Function, LeftEchocardiographyHeart failureLeft ventricular ejection fractionPrognosis

Identifiers

PMID34569712
PMCPMC8712904

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.